Baxter International Inc.

NYSE:BAX Stock Report

Market Cap: US$16.1b

Baxter International Future Growth

Future criteria checks 3/6

Baxter International's revenue is forecast to decline at 3.2% per annum while its annual earnings are expected to grow at 38.5% per year. EPS is expected to grow by 40.7% per annum. Return on equity is forecast to be 14.1% in 3 years.

Key information

38.5%

Earnings growth rate

40.7%

EPS growth rate

Medical Equipment earnings growth12.5%
Revenue growth rate-3.2%
Future return on equity14.1%
Analyst coverage

Good

Last updated04 Feb 2025

Recent future growth updates

Recent updates

Baxter International: An Uncompelling Investment With High Debt

Jan 31

Does Baxter International (NYSE:BAX) Have A Healthy Balance Sheet?

Jan 27
Does Baxter International (NYSE:BAX) Have A Healthy Balance Sheet?

Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Sep 05
Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Baxter- Reiterating Our Buy Rating After A Promising Q2

Aug 07

Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Aug 07
Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Jul 23
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter: Why Investors Should Take Advantage Of The Low Valuation

Jul 16

Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Jul 12
Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

May 30
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

May 14
Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff

May 08

Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Apr 14
Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts

Feb 23

Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Feb 20
Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield

Dec 12

Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?

Oct 12

Dividend Challengers Review: Baxter International

Aug 14

Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF

Jun 12

Earnings and Revenue Growth Forecasts

NYSE:BAX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202712,3571,015N/AN/A3
12/31/202611,7288611,4832,05912
12/31/202511,2276421,1651,73214
12/31/202410,5582861,2281,91012
9/30/202415,0621213911,062N/A
6/30/202414,962985181,174N/A
3/31/202414,892-387071,410N/A
12/31/202314,813-761,0341,726N/A
9/30/202311,379961,1081,634N/A
6/30/202312,389-2,9328881,559N/A
3/31/202314,461-2,6738371,482N/A
12/31/202214,506-2,6665911,211N/A
9/30/202214,275-2,5687921,465N/A
6/30/202213,8928761,1591,850N/A
3/31/202213,3969921,3412,053N/A
12/31/202112,1461,0221,5312,222N/A
9/30/202112,4511,2141,4962,241N/A
6/30/202112,1971,1201,3542,076N/A
3/31/202111,8171,0681,2651,973N/A
12/31/202011,6731,1021,1591,868N/A
9/30/202011,5319111,2361,985N/A
6/30/202011,4109241,4162,176N/A
3/31/202011,5269911,4872,248N/A
12/31/201911,3621,0011,4082,104N/A
9/30/201911,1561,3351,2011,984N/A
6/30/201911,0661,4849811,739N/A
3/31/201911,0601,5059291,698N/A
12/31/201811,0991,5521,2862,017N/A
9/30/201811,0631,0651,0201,699N/A
6/30/201811,009795N/A1,848N/A
3/31/201810,763840N/A2,095N/A
12/31/201710,584609N/A1,714N/A
9/30/201710,4321,025N/A2,036N/A
6/30/201710,283904N/A1,963N/A
3/31/201710,2631,852N/A2,176N/A
12/31/201610,1634,966N/A1,654N/A
9/30/201610,1214,909N/A1,665N/A
6/30/201610,0504,784N/A1,388N/A
3/31/20169,9403,646N/A1,342N/A
12/31/20159,968393N/A1,771N/A
9/30/201510,154337N/A2,190N/A
6/30/201510,376510N/A2,849N/A
3/31/20159,27484N/A2,752N/A
12/31/201410,719457N/A3,215N/A
9/30/201412,252739N/A3,155N/A
6/30/201413,2531,092N/A3,207N/A
3/31/201415,3671,967N/A3,371N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BAX's forecast earnings growth (38.5% per year) is above the savings rate (2.6%).

Earnings vs Market: BAX's earnings (38.5% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: BAX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: BAX's revenue is expected to decline over the next 3 years (-3.2% per year).

High Growth Revenue: BAX's revenue is forecast to decline over the next 3 years (-3.2% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BAX's Return on Equity is forecast to be low in 3 years time (14.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 00:26
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Baxter International Inc. is covered by 45 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Benjamin YeohAtlantic Equities LLP
Daniel OwczarskiAvondale Partners